Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity

Journal of Medical Microbiology

Volumn 48, Issue 5, 1999, Pages 425-431

  Ben Nathan, David ^a,c   Padgett, David A ^a   Loria, Roger M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIOL; HORMONE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; LD 50; LETHALITY; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK;

EID: 0032814358     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-5-425     Document Type: Article

References (40)

1. 1. Ben-Nathan D, Lachmi B, Lustig S, Feuerstein G. Protection of dehydroepiandrosterone in mice infected with viral encephalitis. Arch Virol 1991; 120: 263-271.
2. 2. Ben-Nathan D, Lustig S, Kobiler D, Danenberg HD, Lupu E, Feuerstein G. Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress. J Med Virol 1992; 38: 159-166.
3. 3. Ben-Nathan D, Kobiler D, Feuerstein G, Lustig S. Anti-stress effect of dehydroepiandrosterone (DHEA) on mice inoculated with attenuated arboviruses. Prog Neuroendocrin Immunol 1992; 5: 229-234.
4. 4. Loria RM, Inge TH, Cook SS, Szakal AK, Regelson W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol 1988; 26: 301-314.
5. 5. Loria RM, Padgett DA. Mobilization of cutaneous immunity for systemic protection against infections. Ann NY Acad Sci 1992; 650: 363-366.
6. 6. Loria RM, Padgett DA. Androstenediol regulates systemic resistance against lethal infections in mice. Arch Virol 1992; 127: 103-115.
7. 7. Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA androstenediol. J Neuroimmunol 1997; 78; 203-211.
8. 8. Loria RM, Padgett DA, Huynh PN. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol 1996; 150 suppl: S209-S220.
9. 9. Doggett RG. Microbiology of Pseudomonas aeruginosa. In: Doggett RG (ed) Pseudomonas aeruginosa. Clinical manifestations of infection and current therapy. New York, Academic Press. 1979: 1-7.
10. 10. Jawetz E, Melnick J, Adelberg EA. Medical microbiology. East Norwalk, CT. Appleton and Lange. 1995: 132-134, 218-223.
11. 11. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-production and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci 1995; 36: 9-15.
12. 12. Liu PV. Toxins of Pseudomonas aeruginosa. In: Doggett RG (ed) Pseudomonas aeruginosa. Clinical manifestations of infection and current therapy. New York, Academic Press. 1979: 63-88.
13. 13. Woods DE, Iglewski BH. Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis 1983; 5 Suppl 4: S715-S722.
14. 14. Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 1991; 173: 1305-1310.
15. 15. Morrison DC. Bacterial endotoxins and pathogenesis. Rev Infect Dis 1983; 5 Suppl 4: 733s-747s.
16. 16. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871.
17. 17. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 1986; 232: 977-980.
18. 18. Beutler B, Cerami AC. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 1989; 7: 625-655.
19. 19. Valone FH, Epstein I.B. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. J Immunol 1988; 141: 3945-3950.
20. 20. Vogel SN Havell EA. Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody. Infect Immun 1990; 58: 2397-2400.
21. 21. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991; 59: 4614-4620.
22. 22. Schlessinger D, Schaechter M. Bacterial toxins. In: Schaechter M, Medoff G, Eisenstein BI (eds) Mechanisms of microbial disease, 2nd edn. Baltimore, MD, Williams & Wilkins. 1993: 162-173.
23. 23. Waage A. Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 1988; 63: 299-302.
24. 24 Danenberg HD, Alpert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 1992; 36: 2275-2279.
25. 25. Ben-Nathan D, Maestroni GJM, Conti A. The protective effect of melatonin in viral and bacterial infections. In: Maestroni GJM, Conti A, Reiter RJ (eds) Therapeutic potential of melatonin. Frontiers of Hormone Research, vol 23. Basel, Karger. 1997: 72-80.
26. 26. Kruisbeek AM. Proliferative assays for T cell function. In: JE Coligan AM et al. (eds) Current protocols in immunology. New York, John Wiley and Sons. 1992: 3.12.1-3.12.4.
27. 27. Zuckerman SH, Shellhaas J, Butler LD, Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 1989; 19: 301-305.
28. 28. Hadid R, Spinedi E. Giovambattista A, Chautard T, Gaillard RC. Decreased hypothalamo-pituitary-adrenal axis response to neuroendocrine challenge under repeated endotoxemia. Neuroimmunomodulation 1996; 3: 62-68.
29. 29. Hartung T, Sauer A, Hermann C, Brockhaus F, Wendel A. Overactivation of the immune system by translocated bacteria and bacterial products. Scand J Gastroenterol 1977; 32 Suppl 222: 98-99.
30. 30. Tilders FJH, DeRijk RH, Van Dam A-M, Vincent VAM, Schotanus K, Persoons JHA. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins; routes and intermediate signals. Psychoneuroendocrinology 1994; 19: 209-232.
31. 31. Butler LD, Layman NK, Riedl PF. et al. Neuroendocrine regulation of in vivo cytokine production and effects: 1. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha. J Neuroimmunol 1989; 24: 143-153.
32. 32. Zuckerman SH, Bendele AM. Regulation of serum tumor necrosis factor in glucocorticoid-setisitive and -resistant rodent endotoxin shock models. Infect Immun 1989; 57: 3009-3013.
33. 33. Lázár G, Duda E, Lázàr G. Effect of RU 38486 on TNF production and toxicity. FEBS Lett 1992; 17: 137-140.
34. 34. Engelberg I, Von Asmuth EJU, Van der Linden CJ, Buurman WA. The interrelation between TNF, IL-6 and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine and Cytokine Research 1991; 10: 127-133.
35. 35. Gifford GA, Lohmann-Matthes ML. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 1987; 78: 121-124.
36. 36. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumour necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.
37. 37. Waage A, Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 1988; 167: 1987-1992.
38. 38. Padgett DA, Loria RM. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol 1988; 84: 61-68.
39. 39. Schurr MJ, Fabian TC, Croce MA, Varnavas LE, Proctor KG. Dehydroepiandrosterone, and endogenous immune modulator, after traumatic shock. Shock 1997; 7: 55-59.
40. 40. Dobbs CM, Feng N, Beck FM, Sheridan JF. Neuroendocrine regulation of cytokine production during experimental influenza viral infection. Effects of restrain stress-induced elevation of endogenous corticosterone. J Immunol 1996; 157: 1870-1877.